cnto 6785
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2011 (NCT01288196)
Timeline
Indications
Mechanism of action
- Interleukin 17AINHIBITOR
IL17A inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- cnto 6785
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01966549 | Phase 2 | Nov 1, 2013 | Johnson and Johnson |
| NCT01909427 | Phase 2 | Jun 1, 2013 | Johnson and Johnson |
| NCT01288196 | Phase 1 | Feb 1, 2011 | Johnson and Johnson |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 3 | 3 | 2 | 2011 |
1 organizations
Page 1 / 1